MovDisordV3, PascalFrancis, Checkpoint, bibRecord, 002039

Progressive supranuclear palsy syndrome induced by clebopride

Identifieur interne : 002039 ( PascalFrancis/Checkpoint ); précédent : 002038; suivant : 002040

Progressive supranuclear palsy syndrome induced by clebopride

Auteurs : Jaume Campdelacreu [Espagne] ; Hatice Kumru [Espagne] ; Eduard Tolosa [Espagne] ; Josep Valls-Sole [Espagne] ; Antoni Benabarre [Espagne]

Source :

Movement disorders [ 0885-3185 ] ; 2004.

RBID : Pascal:04-0261660

Descripteurs français

Pascal (Inist)
- Système nerveux pathologie, Clébopride, Antagoniste dopamine, Récepteur dopaminergique.

English descriptors

KwdEn :
- Clebopride, Dopamine antagonist, Dopamine receptor, Nervous system diseases.

Abstract

We report on a patient who presented with a progressive supranuclear palsy (PSP) syndrome while receiving clebopride (CLB), a prokinetic drug with central antidopaminergic properties. The clinical and neurophysiological signs progressively disappeared after CLB withdrawal. To our knowledge, this is the first published PSP-like syndrome attributable to an antidopaminergic drug.

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 002203
to stream PascalFrancis, to step Curation: 000B18

Links to Exploration step

Pascal:04-0261660

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Progressive supranuclear palsy syndrome induced by clebopride</title>
<author><name sortKey="Campdelacreu, Jaume" sort="Campdelacreu, Jaume" uniqKey="Campdelacreu J" first="Jaume" last="Campdelacreu">Jaume Campdelacreu</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Malalties del Sistema Nerviós (ICMSN), Hospital Clínic Universitari</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kumru, Hatice" sort="Kumru, Hatice" uniqKey="Kumru H" first="Hatice" last="Kumru">Hatice Kumru</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Malalties del Sistema Nerviós (ICMSN), Hospital Clínic Universitari</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tolosa, Eduard" sort="Tolosa, Eduard" uniqKey="Tolosa E" first="Eduard" last="Tolosa">Eduard Tolosa</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Malalties del Sistema Nerviós (ICMSN), Hospital Clínic Universitari</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Valls Sole, Josep" sort="Valls Sole, Josep" uniqKey="Valls Sole J" first="Josep" last="Valls-Sole">Josep Valls-Sole</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Malalties del Sistema Nerviós (ICMSN), Hospital Clínic Universitari</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Benabarre, Antoni" sort="Benabarre, Antoni" uniqKey="Benabarre A" first="Antoni" last="Benabarre">Antoni Benabarre</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Psychiatry Service, Hospital Clinic Universitari</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">04-0261660</idno>
<date when="2004">2004</date>
<idno type="stanalyst">PASCAL 04-0261660 INIST</idno>
<idno type="RBID">Pascal:04-0261660</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002203</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000B18</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002039</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Progressive supranuclear palsy syndrome induced by clebopride</title>
<author><name sortKey="Campdelacreu, Jaume" sort="Campdelacreu, Jaume" uniqKey="Campdelacreu J" first="Jaume" last="Campdelacreu">Jaume Campdelacreu</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Malalties del Sistema Nerviós (ICMSN), Hospital Clínic Universitari</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Kumru, Hatice" sort="Kumru, Hatice" uniqKey="Kumru H" first="Hatice" last="Kumru">Hatice Kumru</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Malalties del Sistema Nerviós (ICMSN), Hospital Clínic Universitari</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tolosa, Eduard" sort="Tolosa, Eduard" uniqKey="Tolosa E" first="Eduard" last="Tolosa">Eduard Tolosa</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Malalties del Sistema Nerviós (ICMSN), Hospital Clínic Universitari</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Valls Sole, Josep" sort="Valls Sole, Josep" uniqKey="Valls Sole J" first="Josep" last="Valls-Sole">Josep Valls-Sole</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Malalties del Sistema Nerviós (ICMSN), Hospital Clínic Universitari</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Benabarre, Antoni" sort="Benabarre, Antoni" uniqKey="Benabarre A" first="Antoni" last="Benabarre">Antoni Benabarre</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Psychiatry Service, Hospital Clinic Universitari</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName><settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2004">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Clebopride</term>
<term>Dopamine antagonist</term>
<term>Dopamine receptor</term>
<term>Nervous system diseases</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term>
<term>Clébopride</term>
<term>Antagoniste dopamine</term>
<term>Récepteur dopaminergique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We report on a patient who presented with a progressive supranuclear palsy (PSP) syndrome while receiving clebopride (CLB), a prokinetic drug with central antidopaminergic properties. The clinical and neurophysiological signs progressively disappeared after CLB withdrawal. To our knowledge, this is the first published PSP-like syndrome attributable to an antidopaminergic drug.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>19</s2>
</fA05>
<fA06><s2>4</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Progressive supranuclear palsy syndrome induced by clebopride</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>CAMPDELACREU (Jaume)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>KUMRU (Hatice)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>TOLOSA (Eduard)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>VALLS-SOLE (Josep)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>BENABARRE (Antoni)</s1>
</fA11>
<fA14 i1="01"><s1>Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut Clinic de Malalties del Sistema Nerviós (ICMSN), Hospital Clínic Universitari</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Psychiatry Service, Hospital Clinic Universitari</s1>
<s2>Barcelona</s2>
<s3>ESP</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA20><s1>482-484</s1>
</fA20>
<fA21><s1>2004</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000111581860190</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2004 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>25 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>04-0261660</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>We report on a patient who presented with a progressive supranuclear palsy (PSP) syndrome while receiving clebopride (CLB), a prokinetic drug with central antidopaminergic properties. The clinical and neurophysiological signs progressively disappeared after CLB withdrawal. To our knowledge, this is the first published PSP-like syndrome attributable to an antidopaminergic drug.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Clébopride</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Clebopride</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Cleboprida</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Antagoniste dopamine</s0>
<s5>25</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Dopamine antagonist</s0>
<s5>25</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Antagonista dopamina</s0>
<s5>25</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Récepteur dopaminergique</s0>
<s5>26</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Dopamine receptor</s0>
<s5>26</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Receptor dopaminérgico</s0>
<s5>26</s5>
</fC03>
<fN21><s1>166</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
<affiliations><list><country><li>Espagne</li>
</country>
<region><li>Catalogne</li>
</region>
<settlement><li>Barcelone</li>
</settlement>
</list>
<tree><country name="Espagne"><region name="Catalogne"><name sortKey="Campdelacreu, Jaume" sort="Campdelacreu, Jaume" uniqKey="Campdelacreu J" first="Jaume" last="Campdelacreu">Jaume Campdelacreu</name>
</region>
<name sortKey="Benabarre, Antoni" sort="Benabarre, Antoni" uniqKey="Benabarre A" first="Antoni" last="Benabarre">Antoni Benabarre</name>
<name sortKey="Kumru, Hatice" sort="Kumru, Hatice" uniqKey="Kumru H" first="Hatice" last="Kumru">Hatice Kumru</name>
<name sortKey="Tolosa, Eduard" sort="Tolosa, Eduard" uniqKey="Tolosa E" first="Eduard" last="Tolosa">Eduard Tolosa</name>
<name sortKey="Valls Sole, Josep" sort="Valls Sole, Josep" uniqKey="Valls Sole J" first="Josep" last="Valls-Sole">Josep Valls-Sole</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002039 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 002039 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    RBID
   |clé=     Pascal:04-0261660
   |texte=   Progressive supranuclear palsy syndrome induced by clebopride
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Progressive supranuclear palsy syndrome induced by clebopride

Progressive supranuclear palsy syndrome induced by clebopride

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri